Literature DB >> 21170511

[Symptom management of pain and breathlessness].

S T Simon1, C Müller-Busch, C Bausewein.   

Abstract

Pain and breathlessness are common symptoms in advanced disease. Pain should be treated with a combination of non-opioids and opioids. Coanalgesics play an important role in the treatment of neuropathic pain. Side-effects of opioids should be treated prophylactically but can make opioid rotation necessary. Management of breathlessness needs a combination of non-pharmacological and pharmacological measures. Fans and rollators showed to be effective in relieving breathlessness. Opioids are the drugs of choice for breathlessness. The efficacy of benzodiazepines could not be confirmed, they should only be used as second line therapy. Also, oxygen should only be given regularly after an individual test.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21170511     DOI: 10.1007/s00108-010-2692-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  16 in total

Review 1.  Total dyspnoea.

Authors:  Amy P Abernethy; Jane L Wheeler
Journal:  Curr Opin Support Palliat Care       Date:  2008-06       Impact factor: 2.302

2.  Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated.

Authors:  Alfredo H Navigante; Monica A Castro; Leandro C Cerchietti
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

3.  Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial.

Authors:  Sarah Galbraith; Petrea Fagan; Paul Perkins; Andrew Lynch; Sara Booth
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

Review 4.  Opioids for the palliation of breathlessness in terminal illness.

Authors:  A L Jennings; A N Davies; J P Higgins; K Broadley
Journal:  Cochrane Database Syst Rev       Date:  2001

5.  Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial.

Authors:  Amy P Abernethy; Christine F McDonald; Peter A Frith; Katherine Clark; James E Herndon; Jennifer Marcello; Iven H Young; Janet Bull; Andrew Wilcock; Sara Booth; Jane L Wheeler; James A Tulsky; Alan J Crockett; David C Currow
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

6.  A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease.

Authors:  Joao Paulo Solano; Barbara Gomes; Irene J Higginson
Journal:  J Pain Symptom Manage       Date:  2006-01       Impact factor: 3.612

7.  Mechanisms of improvement in exercise capacity using a rollator in patients with COPD.

Authors:  Vanessa S Probst; Thierry Troosters; Iris Coosemans; Martijn A Spruit; Fabio de Oliveira Pitta; Marc Decramer; Rik Gosselink
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

8.  Mechanisms of exertional dyspnea in patients with cancer.

Authors:  J Travers; D J Dudgeon; K Amjadi; I McBride; K Dillon; P Laveneziana; D Ofir; K A Webb; D E O'Donnell
Journal:  J Appl Physiol (1985)       Date:  2007-11-01

9.  [Morphine and alternative opioids in cancer pain: the EAPC recommendations].

Authors:  L Radbruch; F Nauck
Journal:  Schmerz       Date:  2002-06       Impact factor: 1.107

10.  Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.

Authors:  Amy P Abernethy; David C Currow; Peter Frith; Belinda S Fazekas; Annie McHugh; Chuong Bui
Journal:  BMJ       Date:  2003-09-06
View more
  3 in total

Review 1.  [Update palliative pain therapy].

Authors:  R Rolke; S Rolke; S Hiddemann; M Mücke; H Cuhls; L Radbruch; F Elsner; V Peuckmann-Post
Journal:  Internist (Berl)       Date:  2016-10       Impact factor: 0.743

2.  [Dyspnea, itching and depression in palliative medicine].

Authors:  M Mücke; R Conrad; M Bleckwenn; H Cuhls; L Radbruch; R Rolke
Journal:  Schmerz       Date:  2016-04       Impact factor: 1.107

3.  [Pain management in palliative care. Current aspects of medicinal therapy].

Authors:  H Cuhls; L Radbruch; A Brunsch-Radbruch; G Schmidt-Wolf; R Rolke
Journal:  Internist (Berl)       Date:  2013-02       Impact factor: 0.743

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.